The reduction in klotho levels has been implicated in a variety of kidney pathological conditions, including diabetic kidney disease (DKD), which is the most prevalent cause of end-stage kidney failure, affecting 30–40% of individuals globally with type 1 or type 2 diabetes mellitus (DM) [9, 10]. This evidence concerns the gene KL and diabetes mellitus.